DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Vestipitant is an investigational drug.
There have been 6 clinical trials for Vestipitant. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2006.
The most common disease conditions in clinical trials are Anxiety Disorders, Vomiting, and Postoperative Nausea and Vomiting. The leading clinical trial sponsors are GlaxoSmithKline, Accenture, and [disabled in preview].
Recent Clinical Trials for Vestipitant
|A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)||Accenture||Phase 2|
|Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)||Accenture||Phase 1|
|Vestipitant 28-day Tolerance Study||GlaxoSmithKline||Phase 2|